X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1399) 1399
Publication (90) 90
Book Review (9) 9
Magazine Article (4) 4
Book Chapter (2) 2
Dissertation (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1113) 1113
index medicus (691) 691
male (643) 643
female (588) 588
middle aged (438) 438
adult (434) 434
infectious diseases (399) 399
acinetobacter baumannii (339) 339
aged (339) 339
anti-bacterial agents - therapeutic use (336) 336
acinetobacter infections - microbiology (282) 282
microbiology (280) 280
acinetobacter infections - drug therapy (276) 276
risk factors (265) 265
infections (262) 262
drug resistance, multiple, bacterial (252) 252
acinetobacter-baumannii (249) 249
acinetobacter baumannii - drug effects (219) 219
acinetobacter baumannii - isolation & purification (217) 217
health aspects (208) 208
retrospective studies (207) 207
anti-bacterial agents - pharmacology (202) 202
acinetobacter (198) 198
microbial sensitivity tests (198) 198
mortality (196) 196
antibiotics (187) 187
surgery (184) 184
bacteria (182) 182
nosocomial infections (179) 179
drug resistance in microorganisms (175) 175
epidemiology (170) 170
risk-factors (170) 170
colistin (166) 166
drug resistance (165) 165
acinetobacter infections - complications (164) 164
pneumonia (162) 162
adolescent (155) 155
pharmacology & pharmacy (155) 155
pseudomonas-aeruginosa (152) 152
treatment outcome (150) 150
cross infection - microbiology (149) 149
infection (149) 149
research (142) 142
acinetobacter infections - epidemiology (141) 141
ventilator-associated pneumonia (137) 137
acinetobacter - isolation & purification (135) 135
bacteremia (135) 135
aged, 80 and over (132) 132
intensive care units (126) 126
acinetobacter infections - etiology (124) 124
gram-negative bacteria (122) 122
intensive-care-unit (118) 118
child (114) 114
acinetobacter infections - diagnosis (109) 109
anti-bacterial agents - administration & dosage (108) 108
complications and side effects (107) 107
care and treatment (105) 105
young adult (105) 105
hospitals (104) 104
immunology (104) 104
analysis (103) 103
drug resistance, bacterial (102) 102
cross infection - epidemiology (96) 96
critical care medicine (93) 93
pseudomonas aeruginosa (93) 93
prospective studies (92) 92
bacterial pneumonia (91) 91
colistin - therapeutic use (91) 91
bacteremia - microbiology (90) 90
cross infection - drug therapy (90) 90
cross infection (89) 89
infectious disease (89) 89
meningitis (88) 88
animals (87) 87
acinetobacter infections (85) 85
management (83) 83
medicine (83) 83
antimicrobial resistance (82) 82
critically-ill patients (81) 81
blood-stream infections (79) 79
bacterial infections (78) 78
child, preschool (77) 77
acinetobacter infections - mortality (73) 73
burns - complications (73) 73
medicine, general & internal (73) 73
drug therapy (72) 72
research article (72) 72
infant (71) 71
gram-negative bacterial infections - drug therapy (70) 70
gram-negative bacterial infections - microbiology (70) 70
multidrug resistance (70) 70
patients (70) 70
acinetobacter baumannii - genetics (68) 68
colistin - administration & dosage (66) 66
critical care (65) 65
bacterial infections and mycoses (64) 64
diagnosis (64) 64
klebsiella-pneumoniae (64) 64
acinetobacter - drug effects (63) 63
incidence (63) 63
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1293) 1293
French (29) 29
Spanish (26) 26
Russian (12) 12
Chinese (9) 9
German (8) 8
Japanese (8) 8
Italian (7) 7
Polish (4) 4
Romanian (3) 3
Croatian (1) 1
Czech (1) 1
Korean (1) 1
Persian (1) 1
Portuguese (1) 1
Serbian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Wound Repair and Regeneration, ISSN 1067-1927, 07/2013, Volume 21, Issue 4, pp. 595 - 603
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2014, Volume 9, Issue 4, p. e95042
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 05/2015, Volume 60, Issue 9, pp. 1295 - 1303
Background. With an increase in the use of colistin methansulfonate (CMS) to treat carbapenem-resistant Acinetobacter baumannii infections, colistin resistance... 
Acinetobacter baumannii | Molecular typing | Carbapenem resistance | Colistin resistance | Lipid A | INFECTIOUS DISEASES | INFECTIONS | MANAGEMENT | lipid A | molecular typing | MICROBIOLOGY | IMMUNOLOGY | EMERGENCE | carbapenem resistance | PMRCAB OPERON | SURVEILLANCE | LIPOPOLYSACCHARIDE | colistin resistance | PHOSPHOETHANOLAMINE MODIFICATION | MOLECULAR EPIDEMIOLOGY | MULTIDRUG-RESISTANCE | INSIGHTS | Humans | Middle Aged | Sulbactam - therapeutic use | Male | Acinetobacter Infections - mortality | Multilocus Sequence Typing | Microbial Sensitivity Tests | Carbapenems - pharmacology | Colistin - pharmacology | Drug Resistance, Multiple, Bacterial | Aged, 80 and over | Acinetobacter baumannii - isolation & purification | Adult | Colistin - therapeutic use | Female | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Lipid A - chemistry | Acinetobacter Infections - microbiology | Pneumonia, Ventilator-Associated - drug therapy | Acinetobacter Infections - complications | Ampicillin - therapeutic use | Acinetobacter Infections - drug therapy | Acinetobacter baumannii - pathogenicity | Ethanolamines - chemistry | Electrophoresis, Gel, Pulsed-Field | Carbapenems - therapeutic use | Pneumonia, Ventilator-Associated - microbiology | Aged | Acinetobacter baumannii - drug effects | Acinetobacter baumannii - genetics | Electronic Health Records | Dosage and administration | Research | Colistin | Drug resistance | and Commentaries
Journal Article
Clinical Microbiology and Infection, ISSN 1198-743X, 04/2016, Volume 22, Issue 4, pp. 352 - 358
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2016, Volume 60, Issue 11, pp. 6673 - 6678
With the increasing use of carbapenems, carbapenem-resistant Gram-negative bacteria have become a major concern in health care-associated infections. The... 
Bacteremia - immunology | Hematologic Neoplasms - mortality | Humans | Middle Aged | Pseudomonas aeruginosa - growth & development | Bacteremia - mortality | Male | Stenotrophomonas maltophilia - growth & development | Cross Infection - immunology | Neutropenia - complications | Respiratory Tract Infections - mortality | Neutropenia - mortality | Stenotrophomonas maltophilia - isolation & purification | Acinetobacter baumannii - growth & development | Neutropenia - immunology | Tertiary Care Centers | Risk Factors | Bacteremia - drug therapy | Gram-Negative Bacterial Infections - drug therapy | Cross Infection - drug therapy | Neutropenia - drug therapy | Respiratory Tract Infections - immunology | Survival Analysis | Hematologic Neoplasms - drug therapy | Stenotrophomonas maltophilia - pathogenicity | Pseudomonas aeruginosa - isolation & purification | Cross Infection - mortality | Gram-Negative Bacterial Infections - immunology | Case-Control Studies | Cross Infection - complications | Anti-Bacterial Agents - therapeutic use | Pseudomonas aeruginosa - pathogenicity | Levofloxacin - therapeutic use | Acinetobacter baumannii - isolation & purification | Adult | Female | Respiratory Tract Infections - complications | Hematologic Neoplasms - complications | Length of Stay - statistics & numerical data | Intensive Care Units | Bacteremia - complications | Acinetobacter baumannii - pathogenicity | Gram-Negative Bacterial Infections - complications | Respiratory Tract Infections - drug therapy | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Pseudomonas aeruginosa - drug effects | Stenotrophomonas maltophilia - drug effects | Immunosuppressive Agents - adverse effects | Aged | Hematologic Neoplasms - immunology | Acinetobacter baumannii - drug effects | Gram-Negative Bacterial Infections - mortality
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 5/2003, Volume 36, Issue 9, pp. 1111 - 1118
Journal Article